Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	48	72.9	76.68	108.91	77.83
Cash & Short-Term Investments	48	72.9	76.68	108.91	77.83
Cash Growth	-34.16%	-4.92%	-29.60%	39.93%	22.45%
Other Current Assets	-	-	1.59	2.03	1.92
Total Current Assets	48	72.9	78.26	110.94	79.75
Net Property, Plant & Equipment	2.06	2.07	2.87	2.95	0.64
Other Long-Term Assets	0.34	0.32	0.31	0.3	-
Total Assets	51.78	76.9	81.45	114.19	80.39
Accounts Payable	7.25	7.57	7.95	10.13	5.54
Current Portion of Leases	0.72	0.58	0.54	0.5	0.31
Unearned Revenue	-	-	-	-	1
Total Current Liabilities	7.97	8.15	8.49	10.63	6.84
Long-Term Leases	0.97	0.99	1.57	2.08	0
Other Long-Term Liabilities	35	35	35	35	-
Total Long-Term Liabilities	35.97	35.99	36.57	37.08	0
Total Liabilities	43.94	44.14	45.07	47.71	6.84
Common Stock	0.03	0.03	0.03	0.03	0.02
Additional Paid-in Capital	417.54	408.55	373.93	355.22	329.27
Accumulated Other Comprehensive Income	-0.02	-	-	-	-
Retained Earnings	-409.71	-375.83	-337.58	-288.77	-255.75
Shareholders' Equity	7.83	32.76	36.38	66.48	73.55
Total Liabilities & Equity	51.78	76.9	81.45	114.19	80.39
Total Debt	1.69	1.57	2.11	2.58	0.31
Net Cash (Debt)	46.3	71.33	74.56	106.33	77.52
Net Cash Growth	-35.09%	-4.34%	-29.87%	37.16%	23.39%
Net Cash Per Share	1.48	2.37	2.80	4.40	3.77
Book Value	7.83	32.76	36.38	66.48	73.55
Book Value Per Share	0.25	1.09	1.37	2.75	3.58
Tangible Book Value	7.83	32.76	36.38	66.48	73.55
Tangible Book Value Per Share	0.25	1.09	1.37	2.75	3.58

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q